Sawyer Bawek, DO

Author

Latest Articles
Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

Article

Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

Sawyer Bawek, DO

The 12 Most Anticipated Practice-Changing Abstracts at ESMO 2025: Community Oncologist’s Guide

Article

The 12 Most Anticipated Practice-Changing Abstracts at ESMO 2025: Community Oncologist’s Guide

Sawyer Bawek, DO

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

Article

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

Sawyer Bawek, DO

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Article

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Sawyer Bawek, DO

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Article

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sawyer Bawek, DO

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Article

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Sawyer Bawek, DO